This is a prospective, unblinded, randomized controlled pilot trial to evaluate the impact of the BRIDGE device when used on patients at high risk of opioid withdrawal following opioid exposure.
The investigator team hypothesized that treatment of pediatric intensive care unit (PICU) patients (ages